1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
Thomas Macpherson
Thomas Macpherson
Articles (184)  | Author's Website |

Anatomy of a Failed Investment

While painful, failed investments can provide necessary revisions to your investment process

November 16, 2016 | About:

Better to equivocate, when required, than to show conviction when it is not warranted.

– John Rekenthaler

This episode taught me the importance of always fearing being wrong, no matter how confident I am that I’m right. As a result, I began seeking out the smartest people I could find who disagreed with me so I could understand their reasoning. Only after I fully grasped their points of view could I decide to reject or accept them. By doing this again and again over the years, not only have I increased my chances of being right, but I have also learned a huge amount.”

Ray Dalio (Trades, Portfolio)

As many of you know, over the years I have written about the dangers of high portfolio turnover.

It generally signifies someone is trying to time the markets (bad) and drive up frictional costs that eat up returns (really bad). It doesn't mean high turnover is always the wrong choice, but it certainly isn’t a great sign of a long-term, patient investor. Conversely, maintaining an obstinate position in the face of changing data is little better. An investor has to remain open to changing dynamics about the strengths and weaknesses of an investment thesis.

I bring this up because I generally don’t sell too many positions (my turnover rate since inception at the Nintai Charitable Trust is 5.4% annually). This number could tell me several things. One is that I’m content to let my holdings compound value over the long term (true). Second, I may be holding on to my winners or losers too long (somewhat true). Last, the possibility is that I’m simply too slothful to find new investment opportunities on a weekly basis and spend my time trading (absolutely true).

It’s the second point I want to discuss in particular, hanging on for far too long to my losing positions. It fortunately hasn’t happened too much over the years. But when it does, it’s generally a real doozy. I wrote about one here that I still haven’t lived down. I should make it clear nobody twisted my arm or convinced me to hold on. This was a genuinely unforced error brought on by bad modeling, closed thinking and hubris involving my circle of competence. I have unfortunately committed another such blunder with my investment in Computer Programs and Systems (NASDAQ:CPSI).

Anatomy of a Mistake

It seems like yesterday (it was actually Aug. 1) when I wrote about Computer Programs and Systems in my article “Thoughts on Return on Capital vs. Return of Capital.” In that article I wrote about how I had allocated roughly $400,000 of Nintai Trust dollars only to see that value drop by 25% in the two months I owned it. I made the point that my losses had been mitigated by a dividend yield of roughly 6%. My confidence in my industry knowledge – as well as faith in management – quickly clapped a stopper on any doubts I might have been harboring.

I published my (seemingly) well thought out defense on Aug. 1. One week later the bottom dropped out of the stock price – dropping from $39.10 on Aug. 4 to $27.47 by the end of the day Aug. 5. Just to be clear, at this point my average purchase price was $51.40. The price dropped all the way to $22.90 by Nov. 10 representing a whopping 55% (paper) loss.

So what happened? How in the world did I get an investment so wrong? More importantly, what should I do with it now? Before making a snap decision, I sat down with three years' worth of 10-K, 10-Qs and a list of customers to call to ascertain any long-term change in my estimates. I also looked at my written investment thesis/assumptions and mapped them against actual results. One thing was crystal clear – this was not an example of Murray Gell-Mann’s random accident.[1] Oh, no. As I mentioned, this was a full-blown unforced error with your writer bearing full responsibility. While the results of my review would take an entire article to outline, three findings became apparent that I thought I would share.

Too confident in my circle of competence

Having been in health care consulting for nearly two decades, I assumed Computer Programs and Systems lay well within my circle of competence. To put it succinctly, it wasn’t. I was wildly off in my estimates of market growth, adoption rates, technology implications and impact on Computer Programs and Systems' financials. All of these led me to entirely wrong conclusions and estimates.

Didn't listen to counterarguments

As if erroneous estimates weren’t enough, I chose to ignore counterarguments to my investment thesis. There were warning signs that should have given me pause. As my constitutional law professor used to say, “Extreme cases make bad law.” Information that contradicted my model were regarded as “extreme” and removed from the calculations. In addition, several Nintai board members involved in health care asked some very astute questions. I simply didn’t utilize their expertise. Hubris indeed.

Ignored management’s warnings

In plain sight were warnings by management the electronic health record market in rural hospitals was saturated. While management didn’t state this explicitly, it was clearly moving into the informatics management side of the business. This was further reinforced by its acquisition of Healthland[2]. While I believe it is a wise strategic move, this choice made my initial thesis entirely outdated. My inability to acknowledge this was a key mistake in the process.

What Can Be Learned?

We all know the adage that mistakes are some of the great teachers of wisdom. If that’s the case, I should have a Ph.D. with this investment. That said, I think there are three lessons I can take away and apply going forward.

Write down your investment thesis

You can’t learn from your mistakes if you don’t have a clear record of your choices. In Computer Programs and Systems' case, I had detailed records of my customer interactions, market growth estimates and financial models. All of these – including my assumptions – could be tested against actual events. Let’s just say it wasn’t a very pretty picture.

Track quarterly statements with your thesis

It is vital to take a look at your investment’s 10-Qs with a detailed eye. Information in these – such as the management’s Discussion section – can give you early warning of changes or issues that need to be reflected in your model. Every quarter you should be able to predict – within a range – the chances your investment thesis remains valid.

Have a firm definition on why and when to sell

As conditions change and your investment thesis gets increasingly out of whack, it is no time for what Warren Buffett (Trades, Portfolio) calls “thumb sucking.” A dispassionate look at the data should tell you to buy additional shares, stand pat or sell. You should have firm criteria for this decision making. Whether based on valuation or stock price increase/decrease, it should be clear when you need to act. In my case, thumb sucking has proven to be an expensive mistake.

Readers likely want to know what we did with our holdings in Computer Programs and Systems. I continue to hold my shares for a couple of reasons. The company’s strategy to focus on data and informatics is a solid one. New federal outcomes requirements along with reimbursement tools are already starting to make EMR outcomes data quite valuable. Second is valuation. Since the company has dropped roughly 50% since our purchase we have concluded the stock is undervalued. Building out an entirely new valuation model, current price is probably significantly below my estimated intrinsic value.


Nobody bats 1.000 in baseball or investing. You are sure to make mistakes on the way. As I’ve written before, it’s less about winning and more about not losing. My investment in Computer Programs and Systems clearly violates the latter. Huge losses are hard to recover from even in the long term. Going forward, I’m looking to strengthen my research process. I regularly try to break an investment process through sharp discounts to actual growth. This clearly was not enough in this case. The ability to process alternate views on market assumptions (such as competitors, adoption rates, etc.) needs to take place earlier and be far more robust. The measure of my learning will be the absence of new investments similar to Computer Programs and Systems.

As always I look forward to your thoughts and comments.

[1] Murray Gell-Mann is considered a leader in understanding complex systems. He outlines two key themes – fundamental laws and random accidents. Random accidents are actions where there can be multiple possible outcomes. These accidents – and those that follow – are “frozen” in the history of that system and provide it with complexity. Go here for more information.

[2] The company took on $150 million in long-term debt thereby violating another core requirement in my investment selection process.

Disclosure: The Nintai Charitable Trust is long CPSI.

Start a free seven-day trial of Premium Membership to GuruFocus.

About the author:

Thomas Macpherson
Thomas Macpherson is Managing Director and Chief Investment Officer at Nintai Investments LLC. He is also Chairman of the Board at the Hayashi Foundation, a Japanese-based charity serving special needs children and service pets. The views expressed in his articles are his own and not necessarily those of the firm. He is the author of “Seeking Wisdom: Thoughts on Value Investing.”

Visit Thomas Macpherson's Website

Rating: 5.0/5 (11 votes)



Grahamites - 3 years ago    Report SPAM
Tom - I remember somebody once asked Charlie Munger (Trades, Portfolio) what is the most important habit one can have and Munger shrewdedly pointed out it's the ability to change your mind swiftly when disconfirming evidences emerge. Unfortunately that's just really damn hard. I've had plenty of "oh no" moments and the combination of circle of competency and failing to track competitive environment and moat trend make up the majority.

On a company specific question, it seems like Cerner is moving down the market and Athenahealth is disrupting the small practice and small bed hospitals, so CPSI's facing two very formidable competitors who until recently have not made significant inroads under CPSI's turf. Now that has changed, what gives you the confidence that they can survive in 5 -10 years?

Thomas Macpherson
Thomas Macpherson premium member - 3 years ago

Hi Grahamites. Aaaaahh. If only I could be 1/10th as intelligent as Charlie. I've avoided most blow ups but this one was a real stinker. In regards to CPSI's value prop, I would say the majority of value going forward will be maintenance, consulting, and utilizing their client EMR outcomes data as a tool. I'm not that worried about Cerner or Athena stealing existing customers simply because anybody who has installed (or even worse de-installed then re-installed like I have done twice) knows they will do almost anything to avoid that step. It would be quicker and cleaner for Cerner to simply acquire CPSI and obtain their clients. I may be wrong about the new growth opportunities but having talked to a whole range of customers and management, I'm relatively (that's the operative word!) comfortable with my models. Hope this helps. Thanks again for your comment. Best. - Tom

Varunfriend premium member - 3 years ago

Thanks for an honest and introspective article Tom, it seems to me that fair value is in the 420M - 450M (caveat: i took a real quick look at the numbers and know nothing about the compant specifically).

Would love to hear your thoughts on their compensation and incentive structure. It looks a tad excessive to me. Its interesting that they changed their performance metrics from EPS to Adjusted EPS ... that sort of stuff always makes me take notice.

Thomas Macpherson
Thomas Macpherson premium member - 3 years ago

Hi Varun. Thanks so much for your note. Unfortunately I don't share any of my valuation numbers since joining Dorfman Value so I can't really comment on the first part of your note. In regards to management's compensation, I think over the past decade the leadership has been fairly compenated for the job they've done and value created. The next three to five years will dictate whether they earned continue to earn this or not. The HHI acquisition is a significant addition to CPSI core operations and long term strategy. How they manage its integration will decide whether my views on compensation play out or they lean more in your direction. Hope this helps. Best - Tom.

Praveen Chawla
Praveen Chawla premium member - 3 years ago

Tom, So a mistake was made. What is the next step, do you hold on or walk away? The past is done and gone. With what you know now, will you buy CPSI now? Even for the acquisition potential or the lush dividend.

Thomas Macpherson
Thomas Macpherson premium member - 3 years ago

Hi Praveen. My apologies. I didnt see your note until today. As I mentioned in the article, I intend to hold the stock for now. I wrote, " I continue to hold my shares for a couple of reasons. The company’s strategy to focus on data and informatics is a solid one. New federal outcomes requirements along with reimbursement tools are already starting to make EMR outcomes data quite valuable. Second is valuation. Since the company has dropped roughly 50% since our purchase we have concluded the stock is undervalued. Building out an entirely new valuation model, current price is probably significantly below my estimated intrinsic value." I haven't changed my position since I wrote this. Hope this answers your question. Best - Tom

Please leave your comment:

Performances of the stocks mentioned by Thomas Macpherson

User Generated Screeners

pascal.van.garsseHigh FCF-M2
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
/* */